Opioid Antagonists and Reversal Agents: What PTCB Candidates Must Know

Understanding Opioid Antagonists

Opioid antagonists are critical medications that block opioid receptors, reversing the dangerous effects of opioid overdose. For PTCB exam candidates, understanding these reversal agents is essential for both the test and real-world pharmacy practice.

Naloxone (Narcan)

Naloxone is the most widely recognized opioid reversal agent. It works by competitively binding to mu-opioid receptors, displacing opioids and rapidly reversing respiratory depression. Available formulations include:

• Intranasal spray (4 mg per spray)
• Intramuscular injection (auto-injector)
• Intravenous solution for hospital use

Many states now allow pharmacies to dispense naloxone without a prescription under standing orders, making pharmacy technicians key players in opioid overdose prevention.

Naltrexone

Unlike naloxone, naltrexone is used for long-term maintenance therapy rather than acute reversal. It is available as oral tablets (50 mg daily) and an extended-release intramuscular injection (Vivitrol) given monthly. Naltrexone helps prevent relapse in patients recovering from opioid use disorder.

Key Differences for the PTCB Exam

• Naloxone has a short duration of action (30 to 90 minutes), so repeat dosing may be needed
• Naltrexone should not be started until the patient is opioid-free for 7 to 10 days
• Nalmefene is a longer-acting alternative to naloxone used in some clinical settings

Pharmacy technicians play a vital role in ensuring these medications are stocked, properly stored, and dispensed with appropriate patient education materials. Test your knowledge of opioid pharmacology with our PTCB practice exam or review key drug facts using our flashcard sets.